Legal status of Salvia divinorum

From WikiMD's WELLNESSPEDIA

Legal status of Salvia divinorum refers to the regulations and restrictions applied to the psychoactive plant Salvia divinorum across different jurisdictions worldwide. The plant, native to the cloud forests of Oaxaca, Mexico, has been used traditionally by the Mazatec people for spiritual and medicinal purposes. However, due to its potent hallucinogenic effects, the legal status of Salvia divinorum varies significantly from country to country and even within regions of the same country.

Legal Status by Country[edit]

United States[edit]

In the United States, the legal status of Salvia divinorum is complex and varies by state. While the Drug Enforcement Administration (DEA) has listed Salvia as a "drug of concern", it is not regulated under the Controlled Substances Act at the federal level. However, several states have enacted their own laws to regulate or ban the substance.

United Kingdom[edit]

In the United Kingdom, Salvia divinorum was made illegal in 2016 under the Psychoactive Substances Act. This legislation made it an offense to produce, supply, or import this drug for human consumption.

Australia[edit]

In Australia, Salvia divinorum and its active ingredient, salvinorin A, have been listed as Schedule 9 prohibited substances under the Poisons Standard since 2002.

Legal Status by Region[edit]

European Union[edit]

Within the European Union, the legal status of Salvia divinorum varies. Some countries, such as Denmark, Finland, and Sweden, have made Salvia divinorum and salvinorin A Schedule I substances, while others, like Spain and Italy, have no specific regulations concerning the plant.

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.